<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03970629</url>
  </required_header>
  <id_info>
    <org_study_id>CEU2018-46K</org_study_id>
    <nct_id>NCT03970629</nct_id>
  </id_info>
  <brief_title>ROSA Total Knee Investigational Testing Authorization Study</brief_title>
  <official_title>ROSA Total Knee Investigational Testing Authorization Study: Prospective Single Center Study of the ROSA Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-center clinical study designed to facilitate the collection and&#xD;
      evaluation of workflow efficiency, patient pain and function, and adverse event data. This&#xD;
      clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic&#xD;
      System or conventional instrumentation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to collect and compare clinical outcomes and surgical&#xD;
      data using the ROSA Total Knee robotic instrumentation and conventional instrumentation in&#xD;
      primary total knee arthroplasty.&#xD;
&#xD;
      The assessments will include: Planned vs actual component positioning; Workflow efficiency;&#xD;
      Patient safety based on incidence and frequency of adverse events; Clinical performance&#xD;
      measured by overall pain and function, quality of life data, and radiographic parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EQ-5D questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>EQ-5D</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxford Knee Score Questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>Oxford Knee Score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Knee Pain</condition>
  <condition>Chronic Osteoarthritis</condition>
  <condition>Avascular Necrosis of Femoral Condyle</condition>
  <condition>Moderate Varus, Valgus or Flexion Deformities</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Robotic Assisted TKA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Robotic Assisted TKA via ROSA Robot</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional TKA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional TKA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PERSONA Total Knee</intervention_name>
    <description>Primary Total Knee Arthroplasty</description>
    <arm_group_label>Conventional TKA</arm_group_label>
    <arm_group_label>Robotic Assisted TKA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is a minimum of 18 years of age&#xD;
&#xD;
          2. Pre-op component positioning and sizing plan prior to surgery&#xD;
&#xD;
          3. Independent of study participation, patient is a candidate for primary TKA using the&#xD;
             commercially available Persona knee components implanted in accordance with product&#xD;
             labeling&#xD;
&#xD;
          4. Patient has participated in this study-related Informed Consent process&#xD;
&#xD;
          5. Patient is willing and able to provide written Informed Consent by signing and dating&#xD;
             the IRB or EC approved Informed Consent form&#xD;
&#xD;
          6. Patient is willing and able to complete scheduled study procedures and follow-up&#xD;
             evaluations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient is currently participating in any other surgical intervention studies or pain&#xD;
             management studies&#xD;
&#xD;
          2. Patient has underwent contralateral UKA or TKA within the last 18 months&#xD;
&#xD;
          3. Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head&#xD;
             with collapse, severe dysplasia of the femoral head or the acetabulum)&#xD;
&#xD;
          4. Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture,&#xD;
             chronic severe dislocation)&#xD;
&#xD;
          5. Patient is pregnant or considered a member of a protected population (e.g., prisoner,&#xD;
             mentally incompetent, etc.)&#xD;
&#xD;
          6. Patient has previously received partial or total knee arthroplasty for the ipsilateral&#xD;
             knee&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tory Sears</last_name>
    <phone>5743732125</phone>
    <email>tory.sears@zimmerbiomet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Maisonneuve-Rosemont</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Marquis</last_name>
      <phone>5142523400</phone>
      <phone_ext>5701</phone_ext>
      <email>smarquis.hmr@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Vincent Masse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

